Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FV7V9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,423
Award facts
- Contract value 100% obligated
- $20,423.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,423.46 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 20, 2026, for the supply of Enbrel 50 mg/ml SureClick auto-injector medication. This firm fixed-price delivery order, with an ultimate completion date of January 21, 2026, represents a child order under AmerisourceBergen's parent company Cencora, Inc. (UEI: NWEGNLYTBDW4), and was awarded on a non-competitive, non-set-aside basis. The contract specifies performance at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania.
This delivery order is executed under Cencora's significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.999 billion through December 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. Enbrel, a biologic immunosuppressant medication used to treat rheumatoid arthritis and other autoimmune conditions, falls within the broad scope of this strategic contract vehicle designed to fulfill critical pharmaceutical needs across military treatment facilities and federal medical institutions. AmerisourceBergen's position as a major pharmaceutical distributor and established federal vendor underscores the company's critical role in supporting Department of Defense healthcare operations through this expansive supply agreement.
Quick answers
Who was awarded contract SPE2DR26FV7V9?
SPE2DR26FV7V9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FV7V9 worth?
The government has obligated $20,423 on SPE2DR26FV7V9.
Is contract SPE2DR26FV7V9 an order under another contract?
Yes. SPE2DR26FV7V9 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV7V9 competed?
The extent of competition for SPE2DR26FV7V9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award